Zobrazeno 1 - 10
of 14
pro vyhledávání: '"I. S. Y. Chen"'
Publikováno v:
Journal of Virology. 70:2825-2831
An oligocationic peptide compound (ALX40-4C) was developed for consideration in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. This compound was designed to mimic the basic domain of the HIV-1 transactivation protein, Tat, an
Publikováno v:
Journal of Virology. 68:1258-1263
Human immunodeficiency virus type 1 infection of mononuclear phagocytes has been implicated in disease manifestations, but postentry viral replication events in these cells have not been well characterized. Productive infection of activated T cells i
Autor:
B. Wicks-Beard, Beverly D. Roberts, A. Post, I. S Y Chen, J. Rovnak, M. G. Weiser, G L Cockerell, Michael Dale Lairmore
Publikováno v:
Blood. 78:1532-1537
To determine the susceptibility of rabbits to experimental infection with human T-cell lymphotropic virus type-II (HTLV-II), four separate groups of four weanling rabbits each were inoculated intravenously with lethally irradiated HTLV-II-infected hu
Autor:
S. J. Arrigo, I. S. Y. Chen
Publikováno v:
Genes & Development. 5:808-819
The effect of Rev on cytoplasmic accumulation of the singly spliced human immunodeficiency virus type 1 (HIV-1) vif, vpr, and env/vpu RNAs was examined by using a quantitative RNA polymerase chain reaction (PCR) analysis following transfection of com
Autor:
R G, Amado, I S Y, Chen
Publikováno v:
Current topics in microbiology and immunology. 261
Autor:
I. S. Y. Chen, R. G. Amado
Publikováno v:
Current Topics in Microbiology and Immunology ISBN: 9783642626678
In recent years, enormous advances have been made in our understanding of HIV pathogenesis and in the development of effective therapeutic strategies to combat HIV infection. Combination antiretroviral drugs can effectively reduce HIV RNA in peripher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba4e8e92b19190ae7b566ddae15c058f
https://doi.org/10.1007/978-3-642-56114-6_12
https://doi.org/10.1007/978-3-642-56114-6_12
Autor:
W. G. Tarpley, J. Q. Zhao, S M Poppe, I. S. Y. Chen, T J Dueweke, Mario Stevenson, S. M. Swaney, T. Pushkarskaya
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 90(10)
Several nonnucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) have been described, including Nevirapine, thiobenzimidazolone (TIBO) derivatives, pyridinone derivatives such as L-697,661, and the bis(hetero
Publikováno v:
Journal of virology. 66(5)
Neutralization of human immunodeficiency virus type 1 (HIV-1) infection with soluble CD4 (sCD4) can be achieved over a broad range of concentrations for different virus strains. Laboratory virus strains passaged in transformed T-cell lines are typica
Publikováno v:
AIDS (London, England). 6(5)
OBJECTIVE HIV-1 undergoes extensive genetic variation in infected individuals. The extent of genetic variation has been examined in patients with AIDS, but little is known regarding the appearance of HIV-1 genetic variation immediately following infe
Publikováno v:
Journal of virology. 66(1)
Different isolates of human immunodeficiency virus type 1 (HIV-1) vary in the cell tropisms they display, i.e., the range of cell types in which they are able to establish a productive infection. Here, we report on the phenotypes of recombinants betw